Prof Mark R Hutchinson

Cited by

	All	Since 2017
Citations	11590	6270
h-index	53	41
i10-index	133	113

1400

700

350

1050

200720082009201020112012201320142015201620172018201920202021202284 116 194 317 423 570 666 869 939 988 1032 994 1155 1196 1354 531

Public access

View all

103 articles

11 articles

available

not available

Based on funding mandates

Co-authors

Steven F. MaierUniversity of Colorado BoulderVerified email at colorado.edu
Andrew SomogyiUniversity of Adelaide, Discipline of PharmacologyVerified email at adelaide.edu.au
Peter M. GraceAssociate Professor, University of Texas MD Anderson Cancer Center, HoustonVerified email at mdanderson.org
Hang Hubert YinProfessor & Deputy Dean, School of Pharmaceutical Sciences, Tsinghua UniversityVerified email at tsinghua.edu.cn
Janet CollerSenior Lecturer in Pharmacology, the University of AdelaideVerified email at adelaide.edu.au
Prof Paul RolanUniversity of AdelaideVerified email at adelaide.edu.au
Xiaohui WangPrincipal Investigator (Professor), Chinese Academy of Sciences (CAS)Verified email at ciac.ac.cn
Ewa GoldysProfessor, Deputy Director, Australian Research Council Centre of Excellence for NanoscaleVerified email at unsw.edu.au
Vasiliki StaikopoulosUniversity of Adelaide; Center for NanoScale BiophotonicsVerified email at adelaide.edu.au
Guozhen LiuThe Chinese University of Hong Kong, Shenzhen/The University of New South Wales, SydneyVerified email at cuhk.edu.cn
Sarah A. RobertsonRobinson Research Institute & Adelaide Medical School, University of AdelaideVerified email at adelaide.edu.au
Sanam MustafaUniversity Research Fellow, University of AdelaideVerified email at adelaide.edu.au
Sondra BlandUniversity of Colorado DenverVerified email at ucdenver.edu
Lachlan MoldenhauerRobinson Research Institute, University of AdelaideVerified email at adelaide.edu.au
Erik P SchartnerCentre for Nanoscale BioPhotonics (CNBP), Institute for Photonics and Advanced Sensing, UniversityVerified email at adelaide.edu.au
Jonathan TukeSenior Lecturer, School of Mathematical Sciences, The University of AdelaideVerified email at adelaide.edu.au
Erin D MilliganUniversity of New MexicoVerified email at salud.unm.edu
Heilie KwokFlinders UniversityVerified email at flinders.edu.au
Yibo WangChangchun Institute of Applied Chemistry, Chinese Academy of SciencesVerified email at ciac.ac.cn
Femke Buisman-PijlmanAssociate Professor, University of MelbourneVerified email at unimelb.edu.au

Prof Mark R Hutchinson

Director, ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) & ARC Future Fellow, Adelaide

Verified email at adelaide.edu.au - Homepage

Glia Pain Biophotonics Animal Welfare Neuropharmacology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Pathological pain and the neuroimmune interface PM Grace, MR Hutchinson, SF Maier, LR Watkins Nature Reviews Immunology 14 (4), 217-231, 2014	713	2014
Evidence that opioids may have toll-like receptor 4 and MD-2 effects MR Hutchinson, Y Zhang, M Shridhar, JH Evans, MM Buchanan, TX Zhao, ... Brain, behavior, and immunity 24 (1), 83-95, 2010	487	2010
Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4) MR Hutchinson, Y Zhang, K Brown, BD Coats, M Shridhar, PW Sholar, ... European Journal of Neuroscience 28 (1), 20-29, 2008	421	2008
Glia as the “bad guys”: Implications for improving clinical pain control and the clinical utility of opioids LR Watkins, MR Hutchinson, A Ledeboer, J Wieseler-Frank, ED Milligan, ... Brain, behavior, and immunity 21 (2), 131, 2007	400	2007
Morphine activates neuroinflammation in a manner parallel to endotoxin X Wang, LC Loram, K Ramos, AJ de Jesus, J Thomas, K Cheng, A Reddy, ... Proceedings of the National Academy of Sciences 109 (16), 6325-6330, 2012	392	2012
Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward MR Hutchinson, ST Bland, KW Johnson, KC Rice, SF Maier, LR Watkins The Scientific World Journal 7, 98-111, 2007	392	2007
The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia LR Watkins, MR Hutchinson, KC Rice, SF Maier Trends in pharmacological sciences 30 (11), 581-591, 2009	391	2009
Exploring the Neuroimmunopharmacology of Opioids: An Integrative Review of Mechanisms of Central Immune Signaling and Their Implications for Opioid Analgesia MR Hutchinson, Y Shavit, PM Grace, KC Rice, SF Maier, LR Watkins Pharmacological Reviews 63 (3), 772-810, 2011	384	2011
Glia: novel counter-regulators of opioid analgesia LR Watkins, MR Hutchinson, IN Johnston, SF Maier Trends in neurosciences 28 (12), 661-669, 2005	366	2005
Toll‐like receptor 4 in CNS pathologies MM Buchanan, M Hutchinson, LR Watkins, H Yin Journal of neurochemistry 114 (1), 13-27, 2010	344	2010
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia MR Hutchinson, BD Coats, SS Lewis, Y Zhang, DB Sprunger, N Rezvani, ... Brain, behavior, and immunity 22 (8), 1178-1189, 2008	327	2008
Toll-like receptors in chronic pain L Nicotra, LC Loram, LR Watkins, MR Hutchinson Experimental neurology 234 (2), 316-329, 2012	270	2012
Opioid activation of toll-like receptor 4 contributes to drug reinforcement MR Hutchinson, AL Northcutt, T Hiranita, X Wang, SS Lewis, J Thomas, ... Journal of Neuroscience 32 (33), 11187-11200, 2012	248	2012
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) MR Hutchinson, SS Lewis, BD Coats, DA Skyba, NY Crysdale, ... Brain, behavior, and immunity 23 (2), 240-250, 2009	237	2009
“Listening” and “talking” to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids LR Watkins, MR Hutchinson, ED Milligan, SF Maier Brain research reviews 56 (1), 148-169, 2007	210	2007
Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia MR Hutchinson, AL Northcutt, LW Chao, JJ Kearney, Y Zhang, ... Brain, behavior, and immunity 22 (8), 1248-1256, 2008	187	2008
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β SS Lewis, MR Hutchinson, N Rezvani, LC Loram, Y Zhang, SF Maier, ... Neuroscience 165 (2), 569-583, 2010	182	2010
Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression JM Schwarz, MR Hutchinson, SD Bilbo Journal of Neuroscience 31 (49), 17835-17847, 2011	180	2011
Ibudilast (AV-411) a new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes A Ledeboer, MR Hutchinson, LR Watkins, KW Johnson Expert opinion on investigational drugs 16 (7), 935-950, 2007	164	2007
Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence JK Coller, MR Hutchinson Pharmacology & therapeutics 134 (2), 219-245, 2012	163	2012

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow this author

Cited by

Co-authors